Skip to content
TelegramInformer

Language

Country

All countries

Dermatology Updates

@dermatology_updates Health English

All the atest articles, research and news from worlds leading Dermatology Journals. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

Open in Telegram
Subscribers
9,840
24 hours
+3
7 days
+19
30 days
–
Average post reach
146
Views of a post after 24 hours
Engagement rate
1.5%
Reach ÷ subscribers (ERR)
Posts per day
3.8
Average over 30 days
Mentions
0
By other channels, last 90 days
Interaction rate (ER)
0.03%
Reactions ÷ views, 30 days
Per post, on average
Reactions
0
Reposts
–
Comments
–
Citation index
–
Not cited by other channels in 30 days
Ad posts
0%
0 of 35 posts in 30 days marked as ads

Subscriber growth

Dermatology Updates has 9,840 subscribers. A typical post is seen by about 146 people within a day, an engagement rate of 1.5%.

Daily numbers, last 30 days
Date Subscribers Change Posts Avg. post views
11 Nov 9,840 +3 6 124
10 Nov 9,837 0 3 212
9 Nov 9,837 +2 5 280
8 Nov 9,835 +14 0 –
3 Nov 9,821 +100 1 313
4 Oct 9,721 – 0 –

Views as a post ages

Average views at each age, posts of the last 30 days.

1 h
46
3 h
50
6 h
81
12 h
110
24 h
146
48 h
201
3 days
231

When it posts

Times in UTC. 35 posts in 90 days.

Recent posts

  1. Open post

    • Adding intismeran to pembrolizumab improves recurrence-free survival after melanoma resection INTerpath-001 phase 3 RCT, 1,137 patients with resected stage IIB–IV melanoma: 24-month recurrence-free survival was 82.2% versus 70.0%. Grade ≥3 adverse events occurred in 23.6% versus 20.3%; overall-survival benefit is not established here. Abstract reviewed. NEJM | 11 November 2026 Original study: https://doi.org/10.1056/NEJMoa2609762 Explore more research in this specialty: https://updatesinmedicine.com/research/dermatology

    60 views
  2. Open post

    Geographic Disparities in Medicare Prescribing of Chemopreventive Therapies and Systemic Agents for Advanced Cutaneous Malignancies, 2013-2023 https://www.jaad.org/article/S0190-9622(26)03916-2/fulltext?rss=yes

    128 views
  3. Open post

    Clinical Characteristics, Etiologic Associations, and Treatment Outcomes of Pernio https://jamanetwork.com/journals/jamadermatology/fullarticle/2856414

    141 views
  4. Open post

    Recognizing Autoinflammatory Diseases in Dermatology https://jamanetwork.com/journals/jamadermatology/fullarticle/2856415

    119 views
  5. Open post

    Errors in Figure 2 and the Methods https://jamanetwork.com/journals/jamadermatology/fullarticle/2856416

    106 views
  6. Open post

    Diffuse Lip Swelling and Oral Nodules in an Adolescent https://jamanetwork.com/journals/jamadermatology/fullarticle/2856417

    101 views
  7. Open post

    Dermatology | Research update — 11 November 2026 Brepocitinib improves cutaneous sarcoidosis in a small phase 2 trial BEACON phase 2 (31 participants): 69% on 45 mg achieved clear/almost-clear skin versus 0% on placebo at 16 weeks. Small study; long-term safety remains uncertain. Abstract reviewed. JAMA Dermatol • 2026-11-10 Original article: https://doi.org/10.1001/jamadermatol.2026.5444 Explore more research in this speciality: https://updatesinmedicine.com/research/dermatology

    149 views 2 Reactions
  8. Open post

    Efficacy and Safety of Brepocitinib in Cutaneous Sarcoidosis https://jamanetwork.com/journals/jamadermatology/fullarticle/2856401

    180 views
  9. Open post

    Collagen-PMMA scaffolds induce dermal remodeling and immune recruitment distinct from simple volar fibroblast therapy in human skin https://www.jidonline.org/article/S0022-202X(26)03870-4/fulltext?rss=yes

    238 views
  10. Open post

    Topical sirolimus gel for hyperplastic rosacea: A randomized, double-blind, controlled study and exploration of two-dimensional to three-dimensional approximate protrusion volume (APV) assessment https://www.jaad.org/article/S0190-9622(26)03760-6/fulltext?rss=yes

    219 views

Questions about Dermatology Updates

How many subscribers does Dermatology Updates have?

Dermatology Updates (@dermatology_updates) has 9,840 subscribers as of November 12, 2026.

How many people see a post on Dermatology Updates?

A typical post gets about 150 views within 24 hours, roughly 1% of its subscribers (the ERR).

What is Dermatology Updates about?

It is listed in Health, and posts mostly in English. The channel describes itself as: “All the atest articles, research and news from worlds leading Dermatology Journals. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot”

Where does Dermatology Updates rank?

By subscribers it is #100 in Health, #2,060 among English channels, #2,448 worldwide.

Does Dermatology Updates post ads?

None of its 35 posts in the last 30 days carried an ad label such as #ad or Sponsored. Unlabelled promotions can’t be detected.

Statistics updated 4 minutes ago.